Exhaled Breath Condensate and Respiratory Sequelae in Children Post-COVID-19

被引:2
作者
Klein, Einat Fireman [1 ,2 ]
Yaacoby-Bianu, Karin [2 ,3 ]
Orlin, Ido [4 ]
Zetser, Anna [5 ]
Purits, Nona [3 ]
Livnat, Galit [2 ,3 ]
机构
[1] Carmel Hosp, Pulmonol Div, Haifa, Israel
[2] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Haifa, Israel
[3] Carmel Hosp, Pediat Pulmonol unit, Haifa, Israel
[4] Carmel Hosp, Dept Pediat, Haifa, Israel
[5] Carmel Hosp, Chem Lab, Haifa, Israel
关键词
Exhaled breath condensate; Lung function; Functional capacity; Pediatric respiratory sequelae of severe acute respiratory syndrome coronavirus 2 infection; NORMATIVE DATA; COVID-19; CONSEQUENCES; ANXIETY; STRESS; PH;
D O I
10.1159/000530971
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes an acute respiratory illness. A substantial proportion of adults experience persistent symptoms. There is a paucity of data on respiratory sequelae in children. Exhaled breath condensate (EBC) is a non-invasive tool used to assess airway inflammation. Objectives: This study aimed to evaluate EBC parameters, respiratory, mental and physical ability among children post COVID-19 infection. Methods: Observational study of confirmed SARS-CoV-2 infection cases among children, aged 5-18 years, evaluated once, 1-6 months post positive SARS-CoV-2 PCR testing. All subjects performed spirometry, 6-min walk test (6MWT), EBC (pH, interleukin-6), and completed medical history questionnaires, Depression, Anxiety, and Stress Scale (DASS-21), and physical activity scores. Severity of COVID-19 disease was classified according to WHO criteria. Results: Fifty-eight children were included and classified asymptomatic (n = 14), mild (n = 37), and moderate (n = 7) disease. The asymptomatic group included younger patients compared to the mild and moderate groups (8.9 & PLUSMN; 2.5y vs. 12.3 & PLUSMN; 3.6y and 14.6 & PLUSMN; 2.5y, respectively, p = 0.001), as well as lower DASS-21 total scores (3.4 & PLUSMN; 4 vs. 8.7 & PLUSMN; 9.4 and 8.7 & PLUSMN; 0.6 respectively, p = 0.056), with higher scores in proximity to positive PCR (p = 0.011). No differences were found between the 3 groups regarding EBC, 6MWT, spirometry, body mass index percentile, and activity scores. Conclusions: COVID-19 is an asymptomatic-mild disease in most young healthy children, with gradually diminishing emotional symptoms. Children without prolonged respiratory symptoms revealed no significant pulmonary sequelae as evaluated by EBC markers, spirometry, 6MWT, and activity scores. Larger studies are required to assess long-term pediatric consequences of post SARS-CoV-2 infection, to assess the need for pulmonology surveillance.
引用
收藏
页码:479 / 486
页数:8
相关论文
共 39 条
[1]   Long COVID in Children Observations From a Designated Pediatric Clinic [J].
Ashkenazi-Hoffnung, Liat ;
Shmueli, Einat ;
Ehrlich, Shay ;
Ziv, Adi ;
Bar-On, Ophir ;
Birk, Einat ;
Lowenthal, Alexander ;
Prais, Dario .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (12) :E509-E511
[2]   Exhaled Breath Condensate in Childhood Asthma: A Review and Current Perspective [J].
Bannier, Michiel A. G. E. ;
Rosias, Philippe P. R. ;
Jobsis, Quirijn ;
Dompeling, Edward .
FRONTIERS IN PEDIATRICS, 2019, 7
[3]   Pulmonary long-term consequences of COVID-19 infections after hospital discharge [J].
Blanco, Jose-Ramon ;
Cobos-Ceballos, Maria -Jesus ;
Navarro, Francisco ;
Sanjoaquin, Isabel ;
de las Revillas, Francisco Arnaiz ;
Bernal, Enrique ;
Buzon-Martin, Luis ;
Viribay, Miguel ;
Romero, Lourdes ;
Espejo-Perez, Simona ;
Valencia, Borja ;
Ibanez, David ;
Ferrer-Pargada, Diego ;
Malia, Damian ;
Gutierrez-Herrero, Fernando -Gustavo ;
Olalla, Julian ;
Jurado-Gamez, Bernabe ;
Ugedo, Javier .
CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (06) :892-896
[4]   Exhaled breath condensate biomarkers in COPD [J].
Borrill, Z. L. ;
Roy, K. ;
Singh, D. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 32 (02) :472-486
[5]   Pathophysiology and mechanism of long COVID: a comprehensive review [J].
Castanares-Zapatero, D. ;
Chalon, P. ;
Kohn, L. ;
Dauvrin, M. ;
Detollenaere, J. ;
de Noordhout, C. Maertens ;
Primus-de Jong, C. ;
Cleemput, I ;
Van den Heede, K. .
ANNALS OF MEDICINE, 2022, 54 (01) :1473-1487
[6]   Interleukin-6 in Covid-19: A systematic review andmeta-analysis [J].
Coomes, Eric A. ;
Haghbayan, Hourmazd .
REVIEWS IN MEDICAL VIROLOGY, 2020, 30 (06) :1-9
[7]  
Cooper BG, 2017, BREATHE, V13, pE56, DOI 10.1183/20734735.012717
[8]   Long covid-mechanisms, risk factors, and management [J].
Crook, Harry ;
Raza, Sanara ;
Nowell, Joseph ;
Young, Megan ;
Edison, Paul .
BMJ-BRITISH MEDICAL JOURNAL, 2021, 374
[9]   Exhaled breath testing - A tool for the clinician and researcher [J].
Davis, Michael D. ;
Fowler, Stephen J. ;
Montpetit, Alison J. .
PAEDIATRIC RESPIRATORY REVIEWS, 2019, 29 :37-41
[10]   Long-term Health Consequences of COVID-19 [J].
del Rio, Carlos ;
Collins, Lauren F. ;
Malani, Preeti .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (17) :1723-1724